Results 21 to 30 of about 67,645 (203)

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II) [PDF]

Cardiovascular Diabetology, 2020
Background Cardiometabolic disorders may worsen Covid-19 outcomes. We investigated features and Covid-19 outcomes for patients with or without diabetes, and with or without cardiometabolic multimorbidity.
Ernesto Maddaloni, Luca D’Onofrio, Francesco Alessandri, Carmen Mignogna, Gaetano Leto, Giuseppe Pascarella, Ivano Mezzaroma, Miriam Lichtner, Paolo Pozzilli, Felice Eugenio Agrò, Monica Rocco, Francesco Pugliese, Andrea Lenzi, Rury R. Holman, Claudio Maria Mastroianni, Raffaella Buzzetti, the CoViDiab Study Group   +16 more
doaj   +2 more sources

Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity

Nature Communications
The connection between triglyceride-rich lipoproteins and cardiometabolic multimorbidity, characterized by the concurrence of at least two of type 2 diabetes, ischemic heart disease, and stroke, has not been definitively established.
Yimin Zhao, Zhenhuang Zhuang, Yueying Li, Wendi Xiao, Zimin Song, Ninghao Huang, Wenxiu Wang, Xue Dong, Jinzhu Jia, Robert Clarke, Tao Huang   +10 more
doaj   +2 more sources

Longitudinal sequencing of cardiometabolic multimorbidity among older adults and association with subsequent dementia onset.

PLoS ONE
BackgroundPatterns of development of cardiometabolic multimorbidity (CMM) and the impact of specific cardiometabolic disease combinations on cognitive function are not well understood.
Corey L Nagel, Siting Chen, Heather G Allore, Anda Botoseneanu, Jason T Newsom, Nick Bishop, David A Dorr, Jeffrey Kaye, Ana R Quiñones   +8 more
doaj   +2 more sources

Cardiometabolic multimorbidity in Mexican adults: a cross-sectional analysis of a national survey [PDF]

Frontiers in Medicine
BackgroundCardiometabolic multimorbidity is a rising phenomenon that has been barely explored in middle-income countries such as Mexico.ObjectiveThis study aimed to estimate the prevalence, associated factors, and patterns of cardiometabolic ...
Marcela Agudelo-Botero, Claudio A. Dávila-Cervantes, Liliana Giraldo-Rodríguez   +2 more
doaj   +2 more sources

Cardiometabolic Multimorbidity and Sympathetic Overactivity: Translational Rationale for Combined Hepatic-Renal Denervation. [PDF]

JACC Asia
Cardiometabolic multimorbidity, encompassing type 2 diabetes, hypertension, and metabolic dysfunction–associated steatotic liver disease, is closely linked to sympathetic nervous system overactivity and remains suboptimally controlled by pharmacotherapy alone.
Zhao W, Wu Y, Ji M, Shen L, Cui Z, Wang C, Yao Z, Qian J, Ge J.   +8 more
europepmc   +3 more sources

Multimorbidity of Four Cardiometabolic and Chronic Pulmonary Disease Groups: Prevalence and Attributable Fraction in US Adults, 2007–2012

Journal of Comorbidity, 2017
Background Cardiometabolic and chronic pulmonary diseases may be associated with modifiable risk factors that can be targeted to prevent multimorbidity.
Lisa R. Staimez, Melissa Y. Wei MD, MPH, SM, Min Kim, K. M. Venkat Narayan, Sharon H. Saydah   +4 more
doaj   +3 more sources

Association of Cardiometabolic Multimorbidity With Mortality [PDF]

JAMA, 2015
The prevalence of cardiometabolic multimorbidity is increasing.
Emerging Risk Factors Collaboration, Di Angelantonio, Emanuele, Kaptoge, Stephen, Wormser, David, Willeit, Peter, Butterworth, Adam S, Bansal, Narinder, O'Keeffe, Linda M, Gao, Pei, Wood, Angela M, Burgess, Stephen, Freitag, Daniel F, Pennells, Lisa, Peters, Sanne A, Hart, Carole L, Håheim, Lise Lund, Gillum, Richard F, Nordestgaard, Børge G, Psaty, Bruce M, Yeap, Bu B, Knuiman, Matthew W, Nietert, Paul J, Kauhanen, Jussi, Salonen, Jukka T, Kuller, Lewis H, Simons, Leon A, van der Schouw, Yvonne T, Barrett-Connor, Elizabeth, Selmer, Randi, Crespo, Carlos J, Rodriguez, Beatriz, Verschuren, WM Monique, Salomaa, Veikko, Svärdsudd, Kurt, van der Harst, Pim, Björkelund, Cecilia, Wilhelmsen, Lars, Wallace, Robert B, Brenner, Hermann, Amouyel, Philippe, Barr, Elizabeth LM, Iso, Hiroyasu, Onat, Altan, Trevisan, Maurizio, D'Agostino, Ralph B, Cooper, Cyrus, Kavousi, Maryam, Welin, Lennart, Roussel, Ronan, Hu, Frank B, Sato, Shinichi, Davidson, Karina W, Howard, Barbara V, Leening, Maarten JG, Leening, Maarten, Rosengren, Annika, Dörr, Marcus, Deeg, Dorly JH, Kiechl, Stefan, Stehouwer, Coen DA, Nissinen, Aulikki, Giampaoli, Simona, Donfrancesco, Chiara, Kromhout, Daan, Price, Jackie F, Peters, Annette, Meade, Tom W, Casiglia, Edoardo, Lawlor, Debbie A, Gallacher, John, Nagel, Dorothea, Franco, Oscar H, Assmann, Gerd, Dagenais, Gilles R, Jukema, J Wouter, Sundström, Johan, Woodward, Mark, Brunner, Eric J, Khaw, Kay-Tee, Wareham, Nicholas J, Whitsel, Eric A, Njølstad, Inger, Hedblad, Bo, Wassertheil-Smoller, Sylvia, Engström, Gunnar, Rosamond, Wayne D, Selvin, Elizabeth, Sattar, Naveed, Thompson, Simon G, Danesh, John   +89 more
  +14 more sources

Depressive Symptoms, sleep Disturbance, and Cardiometabolic Multimorbidity Among Adults With Arthritis: A Cross-Sectional Analysis of NHANES 2013-2020. [PDF]

Kaohsiung J Med Sci
ABSTRACT While the association between depressive symptoms and cardiometabolic disease is well established, the relationships among depressive symptoms, sleep disturbance, and cardiometabolic multimorbidity (CMM) in adults with arthritis remain insufficiently understood.
Ma LN, Jiang JC, Lan JJ, Chen YY, Zhang HM, Zeng Y, Huang XH, Tang XN.   +7 more
europepmc   +2 more sources

Dose-Response Relationship Between Triglyceride Glucose-Waist Height Ratio Index and Cardiometabolic Multimorbidity Among Chinese Middle-Aged and Older People. [PDF]

J Clin Lab Anal
Using data from 6674 middle‐aged and older Chinese adults in the China Health and Retirement Longitudinal Study (CHARLS), this study investigated the association between the triglyceride glucose‐waist height ratio (TyG‐WHtR) index and cardiometabolic multimorbidity (CMM).
Li L, Yu Z, Feng Y, Sun C, Hu L, Liu X, Li L, Wu M, Liu L.   +8 more
europepmc   +2 more sources

Comment on "Cardiometabolic Multimorbidity Increases the Risk of Hip Fracture: A Longitudinal Cohort Study Based on CHARLS". [PDF]

Orthop Surg
In the CHARLS cohort of Tian et al., the abstract's 13% versus 8% are column percentages from Table 1: the prevalence of cardiometabolic multimorbidity (CMM) among participants with and without hip fracture. Read across rows, the same counts give a nine‐year hip fracture incidence of 6.6% (36/544) with CMM and 4.4% (251/5770) without, an absolute ...
Sağlıcak H.
europepmc   +2 more sources